Global Cannabis Pharmaceuticals Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Cannabis Pharmaceuticals Market is presumed to reach the market size of nearly USD 191.68 Billion by 2032 from USD 3.97 Billion in 2023 with a CAGR of 53.86% under the study period 2024-2032.

Cannabis pharmaceuticals are medical products derived from the cannabis plant, formulated to treat various health conditions. These pharmaceuticals contain active compounds such as cannabinoids (e.g., THC and CBD) and are available in multiple forms, including oils, capsules, sprays, and topical applications. They are used to manage symptoms of chronic pain, epilepsy, multiple sclerosis, and chemotherapy-induced nausea, among others. These are developed under strict regulatory standards to ensure consistency, safety, and efficacy. Their use is growing as research continues to validate their therapeutic benefits and as legalization expands in many regions.

MARKET DYNAMICS

The growing acceptance & legalization of cannabis for medical use in various countries is primarily during market growth. As more regions recognize the therapeutic benefits of cannabis, the demand for pharmaceutical-grade cannabis products rises. Additionally, growing research and clinical trials demonstrating the efficacy of cannabis in addressing an extensive range of medical conditions, such as epilepsy, chronic pain, and multiple sclerosis, are boosting market growth. The development of standardized cannabis formulations and dosages ensures consistency and safety, making these products more appealing to both healthcare providers and patients. Furthermore, the aging population, which is more prone to conditions that can be treated with cannabis pharmaceuticals, significantly contributes to market demand.

Advances in extraction and formulation technologies are also driving the market, enabling the production of high-quality, pure, and effective cannabis pharmaceuticals. The increasing investment by pharmaceutical companies in the research and development of new cannabis-based therapies is expected to result in innovative products and expanded indications for existing medications. Additionally, growing awareness and acceptance among the medical community and patients regarding the benefits of cannabis pharmaceuticals further drive market growth. However, stringent regulations and societal stigma may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Cannabis Pharmaceuticals. The growth and trends of Cannabis Pharmaceuticals industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Cannabis Pharmaceuticals market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Sativex
Epidiolex
Other Brands

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Cannabis Pharmaceuticals market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cannabis Pharmaceuticals market include Jazz Pharmaceuticals Inc., AbbVie Inc., Insys Therapeutics Inc., Bausch Health Companies Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR112114737

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. CANNABIS PHARMACEUTICALS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL CANNABIS PHARMACEUTICALS MARKET ANALYSIS BY TYPE

5.1. Overview By Type
5.2. Historical and Forecast Data Analysis By Type
5.3. Sativex Historic and Forecast Sales By Regions
5.4. Epidiolex Historic and Forecast Sales By Regions
5.5. Other Brands Historic and Forecast Sales By Regions

6. GLOBAL CANNABIS PHARMACEUTICALS MARKET ANALYSIS BY GEOGRAPHY

6.1. Regional Outlook
6.2. Introduction
6.3. North America Sales Analysis
- 6.3.1 Overview, Historic and Forecast Data Sales Analysis
- 6.3.2 North America By Segment Sales Analysis
- 6.3.3 North America By Country Sales Analysis
- 6.3.4 United States Sales Analysis
- 6.3.5 Canada Sales Analysis
- 6.3.6 Mexico Sales Analysis
6.4. Europe Sales Analysis
- 6.4.1 Overview, Historic and Forecast Data Sales Analysis
- 6.4.2 Europe By Segment Sales Analysis
- 6.4.3 Europe By Country Sales Analysis
- 6.4.4 United Kingdom Sales Analysis
- 6.4.5 France Sales Analysis
- 6.4.6 Germany Sales Analysis
- 6.4.7 Italy Sales Analysis
- 6.4.8 Russia Sales Analysis
- 6.4.9 Rest Of Europe Sales Analysis
6.5. Asia Pacific Sales Analysis
- 6.5.1 Overview, Historic and Forecast Data Sales Analysis
- 6.5.2 Asia Pacific By Segment Sales Analysis
- 6.5.3 Asia Pacific By Country Sales Analysis
- 6.5.4 China Sales Analysis
- 6.5.5 India Sales Analysis
- 6.5.6 Japan Sales Analysis
- 6.5.7 South Korea Sales Analysis
- 6.5.8 Australia Sales Analysis
- 6.5.9 South East Asia Sales Analysis
- 6.5.10 Rest Of Asia Pacific Sales Analysis
6.6. Latin America Sales Analysis
- 6.6.1 Overview, Historic and Forecast Data Sales Analysis
- 6.6.2 Latin America By Segment Sales Analysis
- 6.6.3 Latin America By Country Sales Analysis
- 6.6.4 Brazil Sales Analysis
- 6.6.5 Argentina Sales Analysis
- 6.6.6 Peru Sales Analysis
- 6.6.7 Chile Sales Analysis
- 6.6.8 Rest of Latin America Sales Analysis
6.7. Middle East & Africa Sales Analysis
- 6.7.1 Overview, Historic and Forecast Data Sales Analysis
- 6.7.2 Middle East & Africa By Segment Sales Analysis
- 6.7.3 Middle East & Africa By Country Sales Analysis
- 6.7.4 Saudi Arabia Sales Analysis
- 6.7.5 UAE Sales Analysis
- 6.7.6 Israel Sales Analysis
- 6.7.7 South Africa Sales Analysis
- 6.7.8 Rest Of Middle East And Africa Sales Analysis

7. COMPETITIVE LANDSCAPE OF THE CANNABIS PHARMACEUTICALS COMPANIES

7.1. Cannabis Pharmaceuticals Market Competition
7.2. Partnership/Collaboration/Agreement
7.3. Merger And Acquisitions
7.4. New Product Launch
7.5. Other Developments

8. COMPANY PROFILES OF CANNABIS PHARMACEUTICALS INDUSTRY

8.1. Top Companies Market Share Analysis
8.2. Market Concentration Rate
8.3. Jazz Pharmaceuticals Inc.
- 8.3.1 Company Overview
- 8.3.2 Company Revenue
- 8.3.3 Products
- 8.3.4 Recent Developments
8.4. AbbVie Inc.
- 8.4.1 Company Overview
- 8.4.2 Company Revenue
- 8.4.3 Products
- 8.4.4 Recent Developments
8.5. Insys Therapeutics Inc.
- 8.5.1 Company Overview
- 8.5.2 Company Revenue
- 8.5.3 Products
- 8.5.4 Recent Developments
8.6. Bausch Health Companies Inc
- 8.6.1 Company Overview
- 8.6.2 Company Revenue
- 8.6.3 Products
- 8.6.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies